Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 3—March 2010


Extensively Drug-Resistant Mycobacterium tuberculosis from Aspirates, Rural South Africa

Scott K. HeysellComments to Author , Anthony P. Moll, Neel R. Gandhi, François J. Eksteen, Palav Babaria, Yacoob Coovadia, Lynn Roux, Umesh Lalloo, Gerald Friedland, and N. Sarita Shah
Author affiliations: Tugela Ferry Care and Research Collaboration, Tugela Ferry, South Africa (S.K. Heysell, A.P. Moll, N.R. Gandhi, F.J. Eksteen, P. Babaria, U. Lalloo, G. Friedland, N.S. Shah); University of Virginia, Charlottesville, Virginia, USA (S.K. Heysell); Philanjalo Care Center, Tugela Ferry (A.P. Moll, FJ. Eksteen); Yale University, New Haven, Connecticut, USA (P. Babaria, G. Friedland); Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA (N.R. Gandhi, N.S. Shah); National Health Laboratory Services, Durban, South Africa (Y. Coovadia, L. Roux); Enhancing Care Initiative-KZN, Nelson R. Mandela School of Medicine, Durban (U. Lalloo)

Main Article

Table 2

Comparison of culture yield for Mycobacterium tuberculosis in patients with collection of sputum and either lymph node or pleural fluid aspirate, South Africa, September 1, 2006–December 31, 2008*

Result from sputum Lymph node, n = 9
Pleural fluid, n = 8
DS TB XDR TB No DST No growth DS TB XDR TB No DST No growth
DS TB 2 1 1
XDR TB 1 2 2
No growth 1 2 3 2

*DS TB, drug-susceptible tuberculosis; XDR TB, extensively drug-resistant tuberculosis; DST, drug susceptibility testing.

Main Article